Insulin glargine, a long-acting insulin analog, is essential in managing diabetes, providing steady glucose control over 24 hours. As diabetes cases continue to rise globally, biosimilars of insulin glargine have emerged as affordable alternatives to branded products like Sanofi’s Lantus, reducing the financial burden on healthcare systems and patients alike. Market Outlook for Insulin...

  Sickle Cell Disease (SCD) is a genetic blood disorder that affects the shape and function of red blood cells, leading to severe health complications such as anemia, pain crises, organ damage, and increased susceptibility to infections. The global Sickle Cell Disease Drugs Market has witnessed significant advancements in recent years, driven by growing awareness, advancements in...

An  Electronic Health Record (EHR) is a digital version of a patient’s medical history,  continuously updated by healthcare professionals. Unlike traditional paper records, EHRs combine clinical, operational, and administrative data into a unified platform that provides quick access to patient details. This digital system is key to advancing healthcare technologies,...